<DOC>
	<DOCNO>NCT00959049</DOCNO>
	<brief_summary>The purpose study determine immunogenicity safety profile CSL Limited 's Influenza Virus Vaccine compare US license comparator Influenza Virus Vaccine pediatric population age great equal 6 month le 18 year .</brief_summary>
	<brief_title>A Study Determine Immunogenicity Safety Profile CSL Limited 's Influenza Virus Vaccine Compared US Licensed Comparator Influenza Virus Vaccine Pediatric Population</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy male nonpregnant female participant age ≥ 6 calendar month &lt; 18 year time first study vaccination . For participant age ≥ 6 month &lt; 9 year , bear normal gestation period ( 36 42 week ) . Females childbearing potential ( i.e. , ovulate , premenopausal , surgically sterile ) must abstinent willing use medically accept contraceptive regimen least 2 month vaccination . Females age ≥ 9 year must also return negative urine pregnancy test enrollment . Known hypersensitivity previous dose influenza vaccine allergy egg , chicken protein , neomycin , polymyxin , component Study Vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>